TP53 and neoplasm: Interestingly, treatment of these mice with Cmpd-43 over 3 weeks for PRL2 inhibition had comparable effect on tumor size as the genetic deletion of PRL2 which occurred at the same time as Tp53 deletion, with no obvious adverse effect as also noted previously (24, 37).